Innovar, L.L.C.
Prevention and treatment of viral infection and viral infection-induced organ failure
Compositions for and methods of preventing, reversing or treating viral infection-induced organ failure provided. The compositions are also suitable for treating and/or preventing COVID-19 and influenza. The compositions and methods employ MG53, which can be in the form of recombinant human MG53. The MG53 may also be administered as a composition that expresses and releases MG53 after in vivo administration of said composition to a subject.
OHIO STATE INNOVATION FOUNDATION
A A
A61K A61K
inventional inventional
Matthew A. Adam D. Jianjie Nahush A. Tao Jacob S. Chuanxi Xinyu Bryan A.
Sermersheim Kenney Ma Mokadam Tan Yount Cai Zhou Whitson